BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22434316)

  • 1. Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.
    Zhang Y; Deng ZS; Liao MM; Wang N; Zhang XQ; Yu HY; Zhang YD
    Pathol Oncol Res; 2012 Oct; 18(4):911-6. PubMed ID: 22434316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
    Zhang G; Liu T; Wang Z
    J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.
    Wang XM; Yang LY; Guo L; Fan C; Wu F
    Cancer; 2009 Oct; 115(19):4554-63. PubMed ID: 19551892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
    Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
    Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
    Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Guo X; Xiong L; Zou L; Zhao J
    Pathol Oncol Res; 2012 Jul; 18(3):635-40. PubMed ID: 22350792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
    Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
    Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.
    Zhou P; Chen Z; Chang RM; Jiang W; Wu LL; Wang ZM
    Med Oncol; 2012 Dec; 29(5):3063-9. PubMed ID: 22644917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIB1 as an independent prognostic marker in hepatocellular carcinoma after hepatic resection.
    Song JM; Lu M; Liu FF; Du XJ; Xing BC
    J Gastrointest Surg; 2012 Feb; 16(2):356-60. PubMed ID: 22052107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
    Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
    Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.